Page last updated: 2024-08-17

bromodeoxyuridine and HIV Coinfection

bromodeoxyuridine has been researched along with HIV Coinfection in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adelsberger, JW; Di Mascio, M; Huang, CY; Kovacs, JA; Lane, HC; Lee, PI; Lempicki, RA; Roark, J; Rupert, A; Sereti, I; Srinivasula, S; Stevens, R1
Asaad, R; Bazdar, DA; Jiang, W; Lederman, MM; Rodriguez, B; Sieg, SF1
Burgard, M; Ngo, N; Penit, C; Rabian, C; Rouzioux, C; Tissot, O; Viard, JP1
Adelsberger, JW; Baseler, MW; Betts, MR; Casazza, J; Davey, RT; Douek, DC; Hill, BJ; Keiser, P; Koup, RA; Lempicki, R; Little, SJ; Metcalf, JA; Richman, DD; Stevens, RA; Yoder, C1

Trials

1 trial(s) available for bromodeoxyuridine and HIV Coinfection

ArticleYear
Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes.
    Blood, 2011, Jul-14, Volume: 118, Issue:2

    Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Bromodeoxyuridine; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Proliferation; Female; HIV Infections; HIV-1; Humans; Immunologic Memory; Lymphocyte Count; Male; Middle Aged; Viral Load; Young Adult

2011

Other Studies

3 other study(ies) available for bromodeoxyuridine and HIV Coinfection

ArticleYear
Peripheral S-phase T cells in HIV disease have a central memory phenotype and rarely have evidence of recent T cell receptor engagement.
    The Journal of infectious diseases, 2005, Jul-01, Volume: 192, Issue:1

    Topics: Adult; Antigens, CD; Antiretroviral Therapy, Highly Active; Bromodeoxyuridine; Cell Proliferation; HIV Infections; Humans; Immunologic Memory; Lymphocyte Activation; Lymphocyte Count; Phenotype; Receptors, Antigen, T-Cell; S Phase; T-Lymphocytes; Virus Replication

2005
No evidence for proliferation in the blood CD4+ T-cell pool during HIV-1 infection and triple combination therapy.
    AIDS (London, England), 1998, May-28, Volume: 12, Issue:8

    Topics: Anti-HIV Agents; Bromodeoxyuridine; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cell Division; DNA; Drug Therapy, Combination; Flow Cytometry; Follow-Up Studies; HIV Infections; HIV-1; Humans; Longitudinal Studies; Lymphocyte Activation; RNA, Viral; Viral Load

1998
Evidence for increased T cell turnover and decreased thymic output in HIV infection.
    Journal of immunology (Baltimore, Md. : 1950), 2001, Dec-01, Volume: 167, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antiretroviral Therapy, Highly Active; Bromodeoxyuridine; CD4-Positive T-Lymphocytes; Gene Rearrangement, T-Lymphocyte; HIV Infections; Humans; Immunologic Memory; Interphase; Ki-67 Antigen; Lymphocyte Activation; Middle Aged; T-Lymphocyte Subsets; Thymus Gland

2001